{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T02:56:16Z","timestamp":1776135376686,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T00:00:00Z","timestamp":1681516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T00:00:00Z","timestamp":1681516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Alport syndrome\u00a0is a rare inherited disease resulting from a primary disorder of the glomerular basement membrane. This disease results from mutations in genes encoding alpha chains of type IV collagen. In the differential diagnosis of this disease, IgA nephropathy is the most common primary glomerular disease with gross or microscopic hematuria.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 50-year-old woman was presented with microscopic hematuria and proteinuria of under one gram. Due to the diagnosis of IgA nephropathy in family members, she was treated and followed up for 4\u00a0years as a possible case of IgA nephropathy. Eye examination and audiometry were normal. She underwent renal biopsy with an exacerbation of proteinuria. There was no finding in favor of IgA nephropathy in the histological examination, but the findings of electron microscopy and family history favored Alport syndrome.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This case demonstrates the importance of accurate history and electron microscopy in the complete histological evaluation and diagnosis of glomerular disease. Although in most cases the two can be differentiated based on clinical manifestations, laboratory findings, and histopathological examination, sometimes the association of these two diseases in the families involved or the lack of accurate history and complete histological examinations can complicate the diagnosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-023-03165-7","type":"journal-article","created":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T02:02:07Z","timestamp":1681524127000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Alport syndrome misdiagnosed with IgA nephropathy from familial history: a case report and brief review"],"prefix":"10.1186","volume":"24","author":[{"given":"Hormat","family":"Rahimzadeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanaz","family":"Ajlou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Nili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1216-5913","authenticated-orcid":false,"given":"Effat","family":"Razeghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,15]]},"reference":[{"issue":"5","key":"3165_CR1","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.kint.2017.12.018","volume":"93","author":"CE Kashtan","year":"2018","unstructured":"Kashtan CE, Ding J, Garosi G, Heidet L, Massella L, Nakanishi K, et al. Alport syndrome: a unified classification of genetic disorders of collagen IV \u03b1345: a position paper of the Alport Syndrome Classification Working Group. Kidney Int. 2018;93(5):1045\u201351.","journal-title":"Kidney Int"},{"issue":"5","key":"3165_CR2","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/00005792-199909000-00005","volume":"78","author":"CE Kashtan","year":"1999","unstructured":"Kashtan CE. Alport syndrome. An inherited disorder of renal, ocular, and cochlear basement membranes. Medicine. 1999;78(5):338\u201360. https:\/\/doi.org\/10.1097\/00005792-199909000-00005.","journal-title":"Medicine"},{"issue":"3","key":"3165_CR3","doi-asserted-by":"publisher","first-page":"300060519891290","DOI":"10.1177\/0300060519891290","volume":"48","author":"W Hao","year":"2020","unstructured":"Hao W, Ao L, Zhang C, Zhu L, Xie D. IgA nephropathy suspected to be combined with Fabry disease or Alport syndrome: a case report. J Int Med Res. 2020;48(3):300060519891290. https:\/\/doi.org\/10.1177\/0300060519891290.","journal-title":"J Int Med Res"},{"issue":"1","key":"3165_CR4","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12882-017-0527-4","volume":"18","author":"V Gillion","year":"2017","unstructured":"Gillion V, Jadoul M, Aydin S, Godefroid N. ANCA vasculitis in a patient with Alport syndrome: a difficult diagnosis but a treatable disease! BMC Nephrol. 2017;18(1):105. https:\/\/doi.org\/10.1186\/s12882-017-0527-4.","journal-title":"BMC Nephrol"},{"issue":"2","key":"3165_CR5","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1093\/ndt\/gfq665","volume":"26","author":"A McGrogan","year":"2011","unstructured":"McGrogan A, Franssen CF, de Vries CS. The incidence of primary glomerulonephritis worldwide: a systematic review of the literature. Nephrol Dial Transplant. 2011;26(2):414\u201330. https:\/\/doi.org\/10.1093\/ndt\/gfq665.","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"3165_CR6","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1371\/journal.pgen.1002765","volume":"8","author":"K Kiryluk","year":"2012","unstructured":"Kiryluk K, Li Y, Sanna-Cherchi S, Rohanizadegan M, Suzuki H, Eitner F, et al. Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis. PLoS Genet. 2012;8(6):2765.","journal-title":"PLoS Genet"},{"issue":"3","key":"3165_CR7","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/cge.12258","volume":"86","author":"C Fallerini","year":"2014","unstructured":"Fallerini C, Dosa L, Tita R, Del Prete D, Feriozzi S, Gai G, et al. Unbiased next generation sequencing analysis confirms the existence of autosomal dominant Alport syndrome in a relevant fraction of cases. Clin Genet. 2014;86(3):252\u20137. https:\/\/doi.org\/10.1111\/cge.12258.","journal-title":"Clin Genet"},{"issue":"12","key":"3165_CR8","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1681\/ASN.2013080912","volume":"25","author":"V Morini\u00e8re","year":"2014","unstructured":"Morini\u00e8re V, Dahan K, Hilbert P, Lison M, Lebbah S, Topa A, et al. Improving mutation screening in familial hematuric nephropathies through next generation sequencing. J Am Soc Nephrol. 2014;25(12):2740\u201351. https:\/\/doi.org\/10.1681\/ASN.2013080912.","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"3165_CR9","first-page":"1016","volume":"4","author":"JM Pochet","year":"1989","unstructured":"Pochet JM, Bobrie G, Landais P, Goldfarb B, Gr\u00fcnfeld JP. Renal prognosis in Alport\u2019s and related syndromes: influence of the mode of inheritance. Nephrol Dial Transplant. 1989;4(12):1016\u201321.","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"3165_CR10","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1093\/ndt\/gfn681","volume":"24","author":"E Marcocci","year":"2009","unstructured":"Marcocci E, Uliana V, Bruttini M, Artuso R, Silengo MC, Zerial M, et al. Autosomal dominant Alport syndrome: molecular analysis of the COL4A4 gene and clinical outcome. Nephrol Dial Transplant. 2009;24(5):1464\u201371.","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"3165_CR11","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1053\/j.ajkd.2020.03.026","volume":"77","author":"CE Kashtan","year":"2021","unstructured":"Kashtan CE. Alport syndrome: achieving early diagnosis and treatment. Am J Kidney Dis. 2021;77(2):272\u20139. https:\/\/doi.org\/10.1053\/j.ajkd.2020.03.026.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"3165_CR12","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.xkme.2020.05.014","volume":"2","author":"BA Warady","year":"2020","unstructured":"Warady BA, Agarwal R, Bangalore S, Chapman A, Levin A, Stenvinkel P, et al. Alport syndrome classification and management. Kidney Med. 2020;2(5):639\u201349. https:\/\/doi.org\/10.1016\/j.xkme.2020.05.014.","journal-title":"Kidney Med"},{"issue":"6","key":"3165_CR13","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/s0272-6386(12)80840-7","volume":"19","author":"J Chahin","year":"1992","unstructured":"Chahin J, Ortiz A, Mendez L, Gallego E, Garcia-Perez J, Garcia-Castro G, et al. Familial IgA nephropathy associated with bilateral sensorineural deafness. Am J Kidney Dis. 1992;19(6):592\u20136. https:\/\/doi.org\/10.1016\/s0272-6386(12)80840-7.","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"3165_CR14","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1097\/01.asn.0000090034.71205.74","volume":"14","author":"JP Jais","year":"2003","unstructured":"Jais JP, Knebelmann B, Giatras I, De Marchi M, Rizzoni G, Renieri A, et al. X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a \u201cEuropean Community Alport Syndrome Concerted Action\u201d study. J Am Soc Nephrol. 2003;14(10):2603\u201310. https:\/\/doi.org\/10.1097\/01.asn.0000090034.71205.74.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"3165_CR15","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1046\/j.1523-1755.1999.0550031051.x","volume":"55","author":"L Call\u00eds","year":"1999","unstructured":"Call\u00eds L, Vila A, Carrera M, Nieto J. Long-term effects of cyclosporine A in Alport\u2019s syndrome. Kidney Int. 1999;55(3):1051\u20136. https:\/\/doi.org\/10.1046\/j.1523-1755.1999.0550031051.x.","journal-title":"Kidney Int"},{"issue":"2","key":"3165_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15761\/TiT.1000278","volume":"13","author":"F Alalawi","year":"2020","unstructured":"Alalawi F, Alnour H, Kossi ME, Jenkins JR, Halawa A. BK virus infection in adult renal transplant recipients; risk factors and their impact on allograft survival. Trends Transplant. 2020;13(2):1. https:\/\/doi.org\/10.15761\/TiT.1000278.","journal-title":"Trends Transplant"},{"key":"3165_CR17","doi-asserted-by":"publisher","first-page":"164016","DOI":"10.1155\/2013\/164016","volume":"2013","author":"SI Armstead","year":"2013","unstructured":"Armstead SI, Hellmark T, Wieslander J, Zhou XJ, Saxena R, Rajora N. A case of alport syndrome with posttransplant antiglomerular basement membrane disease despite negative antiglomerular basement membrane antibodies by EIA treated with plasmapheresis and intravenous immunoglobulin. Case Rep Transplant. 2013;2013:164016. https:\/\/doi.org\/10.1155\/2013\/164016.","journal-title":"Case Rep Transplant"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-023-03165-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-023-03165-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-023-03165-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T02:02:35Z","timestamp":1681524155000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-023-03165-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,15]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3165"],"URL":"https:\/\/doi.org\/10.1186\/s12882-023-03165-7","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,15]]},"assertion":[{"value":"21 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate:"}},{"value":"Informed consent was obtained in both written and verbal format from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"97"}}